All articles tagged with #us food and drug administration
An FDA Pharmacy Compounding Advisory Committee voted to recommend loosening regulations on six peptide therapies—BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500—potentially enabling prescription-based access if the FDA approves; supporters hail a win for personalized medicine, but FDA scientists have warned there isn’t enough data on safety and efficacy, and a final decision could take months.
Approximately 1.5 million dozen white and brown cage-free eggs from Midwest Poultry Services have been recalled for potential Salmonella contamination, sold at Brookshire Grocery stores in Texas, Louisiana, Oklahoma, Arkansas, New Mexico and Mississippi and Kroger stores in Texas and Louisiana. Sell-by dates range from July 20 to August 17. Look for codes P-1950 or 0840962 and Julian dates 157–184 to identify affected eggs. Consumers who bought these eggs should discard them or return them, and monitor for symptoms of Salmonella infection.
An ongoing cyclosporiasis outbreak linked to Taylor Farms iceberg lettuce has sickened more than 7,000 people nationwide. Despite a Taylor Farms recall and Sysco halting distribution from Mexico, investigators are still determining the source, while health authorities urge consumers to avoid recalled lettuce, check packaging details, and follow FDA/CDC guidance as the investigation continues.
The Trump administration is laying groundwork for chatbots that can diagnose illness and prescribe medicine, hoping to address doctor shortages, but physicians warn AI could bring safety, liability and bias concerns. A Washington Post story highlights a real case where a patient’s AI-assisted diagnosis led to a clinical-trial entry, illustrating AI’s potential to augment care alongside significant regulatory and safety challenges.
The Supreme Court issued a temporary order allowing patients to continue receiving the abortion pill mifepristone by mail for one week as it weighs emergency appeals from drugmakers challenging a lower-court ruling that required in-person pickup.
A federal appeals court temporarily reinstated the rule that abortion pills must be picked up in person, blocking access via mail and telehealth. The decision, tied to Louisiana’s suit against the FDA, is a win for antiabortion advocates and will affect access in states with bans while manufacturers seek to pause or challenge the ruling.
The Washington Post’s The Post's View argues that RFK Jr.’s push to loosen peptide regulations contradicts FDA scientists’ warnings that many peptides are ineffective and potentially dangerous, accusing him of hypocrisy for promoting an experimental wellness trend while doubting vaccines.
Vinay Prasad, the FDA’s controversial head of vaccines and complex therapies, will step down at the end of April after a tenure marked by divisive drug and vaccine decisions and a push to tighten vaccine approvals; his tenure included a prior brief removal and quick reinstatement in 2025.
An oncologist notes that while most dietary supplements aren’t harmful, some—particularly antioxidants for immunocompromised patients—should be used with caution. There’s no clear evidence that supplements prevent cancer, and their use can raise safety and interaction concerns with cancer therapies; patients should discuss any supplement plan with their clinician and be mindful of regulatory and safety considerations.